Genome-wide association analysis and Mendelian randomization proteomics identify novel protein biomarkers and drug targets for primary prevention of heart failure
Danielle Rasooly, Gina Marie Peloso, Alexandre C. Pereira, Hesam Dashti, Claudia Giambartolomei, Eleanor Wheeler, Nay Aung, Brian R. Ferolito, Maik Pietzner, Eric H. Farber‐Eger, Quinn Stanton Wells, Nicole Kosik, Liam Gaziano, Daniel C. Posner, A. Patrícia Bento, , Juan Pablo Casas
This study identifies novel genetic risk variants and potential drug targets for heart failure using GWAS and Mendelian randomization proteomics.
Nature Communications · Jul 10, 2023Peer-reviewedGenetic & Genomic Medicine